SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > NanoViricides Inc. (NNVC)

As if they never mentioned many of their

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Its_lose_not_loose Member Profile
Member Level 
Followed By 7
Posts 4,309
Boards Moderated 0
Alias Born 09/11/13
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 11/22/2017 4:23:23 PM
NanoViricides Files Quarterly Report for Period Ending September 30, 2017 "PR Newswire (US)" - 11/20/2017 7:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/14/2017 5:25:18 PM
Revised Proxy Soliciting Materials (definitive) (defr14a) "Edgar (US Regulatory)" - 11/8/2017 5:18:02 PM
NanoViricides Provides Further Details on Its Herpes-Induced Acute Retinal Necrosis Animal Study to be Presented On November ... "PR Newswire (US)" - 11/6/2017 7:00:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 10/27/2017 6:08:02 AM
Excellent Results in Inhibiting Shingles Virus in Human Skin: NanoViricides Extends Agreement with SUNY Upstate Medical Cente... "PR Newswire (US)" - 10/26/2017 7:00:00 AM
NanoViricides to Present Results On Successful Treatment Of Herpes-Induced Acute Retinal Necrosis at the Annual Meeting of th... "PR Newswire (US)" - 10/17/2017 7:00:00 AM
NanoViricides Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical Trials "PR Newswire (US)" - 9/29/2017 7:30:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 9/28/2017 4:51:22 PM
NanoViricides, Inc. Announces its CEO Dr. Seymour to Present at the 19th Annual Rodman & Renshaw Global Investment Conference... "PR Newswire (US)" - 9/11/2017 9:04:00 AM
NanoViricides Reports Its Drug Candidates Significantly Reduced the Extent of Shingles Virus Infection of Human Skin "PR Newswire (US)" - 7/10/2017 7:00:00 AM
NanoViricides' Poster "Novel NanoviricidesĀ® Highly Effective Against Varicella Zoster Virus in Cell Culture" to be Presented... "PR Newswire (US)" - 6/26/2017 9:00:00 AM
NanoViricides Abstract Accepted for Poster Presentation at the 2017 Annual Meeting of American Society of Virology "PR Newswire (US)" - 6/20/2017 7:00:00 AM
NanoViricides CEO to Present Information on Its Topical Shingles Treatment At the 2017 Marcum Investor Conference in New York... "PR Newswire (US)" - 6/13/2017 7:00:00 AM
NanoViricides Reports Excellent Inhibitory Effects of Its Topical Shingles Treatment Candidates Against VZV in Multiple Cell ... "PR Newswire (US)" - 6/6/2017 5:30:00 PM
NanoViricides Files Quarterly Report for Period Ending 2017-03-31 "PR Newswire (US)" - 5/16/2017 7:50:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/15/2017 5:03:04 PM
NanoViricides CEO Dr. Seymour to Present an Update on the Company at The Planet Microcap Showcase - 2017 in Las Vegas; Compan... "PR Newswire (US)" - 4/26/2017 5:00:00 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 4/26/2017 6:02:18 AM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 4/18/2017 4:57:18 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 3/1/2017 6:10:07 AM
NanoViricides Files Quarterly Report for Period Ending 2016-12-31 "PR Newswire (US)" - 2/16/2017 7:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/14/2017 6:02:28 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/13/2017 5:33:10 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist